How body composition affects outcomes in lung transplantation
The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation.
This study is looking at how body weight and muscle health affect recovery and quality of life for people getting a lung transplant, so we can better support patients during their healing process.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11144645 on NIH RePORTER |
What this research studies
This research investigates the relationship between body composition and outcomes for patients undergoing lung transplantation. It focuses on understanding how factors like obesity and sarcopenia (muscle loss) impact recovery and quality of life after surgery. The study uses advanced methods such as bioelectrical impedance to assess body composition, aiming to identify patients at higher risk for complications. By analyzing these factors, the research seeks to improve patient care and outcomes in lung transplant recipients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are being considered for lung transplantation and may have concerns related to their body composition.
Not a fit: Patients who are not candidates for lung transplantation or those with stable body composition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better preoperative assessments and tailored interventions that enhance recovery and quality of life for lung transplant patients.
How similar studies have performed: Previous research has indicated that body composition significantly impacts surgical outcomes, suggesting that this approach could yield valuable insights.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Singer, Jonathan Paul — University of California, San Francisco
- Study coordinator: Singer, Jonathan Paul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.